BCAX — BICARA THERAPEUTICS INC

Ownership history in Deep Track Capital, LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which Deep Track Capital, LP reported a position in BICARA THERAPEUTICS INC (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.3% (2024 Q4)
Avg. % of fund
0.89%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,614,004 +187,347 +7.7% 0.78% $44.0M $16.83
2025 Q3 UNCHANGED 2,426,657 — 0% 1.07% $38.3M $15.79
2025 Q2 ADDED 2,426,657 +426,657 +21.3% 0.72% $22.5M $9.29
2025 Q1 UNCHANGED 2,000,000 — 0% 0.84% $26.1M $13.03
2024 Q4 ADDED 2,000,000 +1,203,148 +151.0% 1.30% $34.8M $17.42
2024 Q3 INITIATED 796,852 — — 0.64% $20.3M $25.47
% of Fund (quarterly)    BCAX price (monthly, adj. close)

Other funds also holding BCAX

As of 2025 Q4 — sorted by position size

Omega Fund Management, LLC 3Y 7Y 12.95% ACORN CAPITAL ADVISORS, LLC 3.67% Siren, L.L.C. 2.62% Vestal Point Capital, LP 2.05% Aisling Capital Management LP 3Y 7Y 2.0% TPG GP A, LLC 3Y 1.89% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.2% DAFNA Capital Management LLC 3Y 7Y 1.02% Palo Alto Investors LP 3Y 7Y 0.7% Atle Fund Management AB 3Y 7Y 0.6%
← Back to Deep Track Capital, LP Holdings